Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Nyxoid 1.8 mg nasal spray, solution in a single-dose container

Active Ingredient:
naloxone hydrochloride dihydrate
Company:  
Napp Pharmaceuticals Limited See contact details
ATC code: 
V03AB15
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Audio/Video HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Nyxoid - Healthcare Professional Guidance Document

{healthcare_pro_orange} For Healthcare Professionals

To provide brief information for HCPs on Nyxoid

{pdf_link}

Nyxoid Patient Information Card

Information on: How to recognise symptoms of an opioid overdose, What to do, How to give Nyxoid and How to recognise acute withdrawal symptoms

{pdf_link}

Nyxoid - Training Card

Training Card for Patients and Carers

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Napp Pharmaceuticals Limited
Company image
Address
Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0GW
WWW
http://www.napp.co.uk
Telephone
+44 (0)1223 424 444
Medical Information e-mail
[email protected]